当前位置:首页 - 行情中心 - 圣达生物(603079) - 财务分析 - 现金流量表

圣达生物

(603079)

  

流通市值:30.16亿  总市值:33.31亿
流通股本:1.71亿   总股本:1.89亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金410,427,102.53190,106,736.12813,296,840.86601,476,387.73
  收到的税费返还16,623,182.8611,970,390.1621,411,511.3718,081,333.7
  收到其他与经营活动有关的现金6,932,080.245,719,777.0217,919,731.6710,764,530.86
  经营活动现金流入小计433,982,365.63207,796,903.3852,628,083.9630,322,252.29
  购买商品、接受劳务支付的现金291,722,566.74162,936,369.6502,745,061.37389,201,527.69
  支付给职工以及为职工支付的现金77,205,480.4747,991,474.71126,094,150.52105,091,549.22
  支付的各项税费25,411,932.0711,582,533.9335,045,66925,964,098.15
  支付其他与经营活动有关的现金16,677,920.46,408,262.1440,865,099.7128,791,099.07
  经营活动现金流出小计411,017,899.68228,918,640.38704,749,980.6549,048,274.13
  经营活动产生的现金流量净额22,964,465.95-21,121,737.08147,878,103.381,273,978.16
二、投资活动产生的现金流量:
  收回投资收到的现金569,286,37588,000,000275,000,000105,000,000
  取得投资收益收到的现金754,511.08449,777.4723,526.923,015,295.08
  处置固定资产、无形资产和其他长期资产收回的现金净额116,537.930,5341,307,613.96184,273
  投资活动现金流入小计570,157,423.9888,480,311.4277,031,140.88108,199,568.08
  购建固定资产、无形资产和其他长期资产支付的现金71,157,258.2139,102,951.43169,845,643.09132,517,450.35
  投资支付的现金581,211,23592,572,485291,551,375191,286,375
  投资活动现金流出小计652,368,493.21131,675,436.43461,397,018.09323,803,825.35
  投资活动产生的现金流量净额-82,211,069.23-43,195,125.03-184,365,877.21-215,604,257.27
三、筹资活动产生的现金流量:
  吸收投资收到的现金264,529,990---
  取得借款收到的现金100,000,00025,000,000153,000,000132,000,000
  筹资活动现金流入小计364,529,99025,000,000153,000,000132,000,000
  偿还债务支付的现金77,000,000-129,900,000130,204,323.57
  分配股利、利润或偿付利息支付的现金3,745,235.281,883,46518,070,610.3216,257,071.36
  支付其他与筹资活动有关的现金1,746,081.22-14,376,020.8413,947,005.6
  筹资活动现金流出小计82,491,316.51,883,465162,346,631.16160,408,400.53
  筹资活动产生的现金流量净额282,038,673.523,116,535-9,346,631.16-28,408,400.53
四、汇率变动对现金及现金等价物的影响712,737.1857,892.743,475,474.432,419,975.29
五、现金及现金等价物净增加额223,504,807.4-41,142,434.37-42,358,930.64-160,318,704.35
  加:期初现金及现金等价物余额263,508,597.32263,508,597.32305,867,527.96305,867,527.96
  期末现金及现金等价物余额487,013,404.72222,366,162.95263,508,597.32145,548,823.61
补充资料:
  净利润40,495,558.21-37,257,648.89-
  资产减值准备933,206.09-10,643,054.89-
  固定资产和投资性房地产折旧32,184,710.46-67,267,610.41-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧32,184,710.46-67,267,610.41-
  无形资产摊销3,748,760.61-6,828,514.57-
  长期待摊费用摊销2,416,063.61-4,868,871.2-
  处置固定资产、无形资产和其他长期资产的损失86,177.7--145,968.82-
  固定资产报废损失--291,810.47-
  公允价值变动损失958.36--1,210.56-
  财务费用-285,413.35--1,399,310.31-
  投资损失-754,511.08--1,452,570.6-
  递延所得税-497,393.87-258,223.95-
  其中:递延所得税资产减少-421,952.67-825,267.77-
    递延所得税负债增加-75,441.2--567,043.82-
  存货的减少-46,728,453.48-19,373,363.36-
  经营性应收项目的减少333,533,988.29--45,288,873.67-
  经营性应付项目的增加-342,480,464.37-40,384,987.17-
  其他--2,703,201.96-
  现金的期末余额487,013,404.72-263,508,597.32-
  减:现金的期初余额263,508,597.32-305,867,527.96-
  现金及现金等价物的净增加额223,504,807.4--42,358,930.64-
公告日期2025-08-262025-04-282025-04-282024-10-26
审计意见(境内)标准无保留意见
TOP↑